Michele Caggana

6.4k total citations
135 papers, 3.3k citations indexed

About

Michele Caggana is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michele Caggana has authored 135 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 35 papers in Genetics and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michele Caggana's work include Metabolism and Genetic Disorders (26 papers), Lysosomal Storage Disorders Research (20 papers) and Prenatal Screening and Diagnostics (19 papers). Michele Caggana is often cited by papers focused on Metabolism and Genetic Disorders (26 papers), Lysosomal Storage Disorders Research (20 papers) and Prenatal Screening and Diagnostics (19 papers). Michele Caggana collaborates with scholars based in United States, China and Australia. Michele Caggana's co-authors include James N. Turner, Hisham Mohamed, Joseph J. Orsini, Kenneth A. Pass, Carlos A. Saavedra‐Matiz, Denise M. Kay, Charlotte M. Druschel, James M. Conroy, Arlene I. Ramsingh and Melissa Wasserstein and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Environmental Science & Technology.

In The Last Decade

Michele Caggana

130 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Caggana United States 31 1.1k 615 541 477 463 135 3.3k
Elena Levtchenko Belgium 41 1.9k 1.7× 570 0.9× 657 1.2× 2.1k 4.4× 124 0.3× 257 6.4k
Fred Lorey United States 31 776 0.7× 303 0.5× 451 0.8× 1.1k 2.3× 693 1.5× 78 2.9k
Angelo Minucci Italy 26 641 0.6× 335 0.5× 376 0.7× 504 1.1× 121 0.3× 170 2.3k
Rikke Nielsen Denmark 35 1.5k 1.4× 527 0.9× 389 0.7× 322 0.7× 120 0.3× 68 4.1k
David Dimmock United States 33 1.7k 1.5× 466 0.8× 1.8k 3.3× 499 1.0× 1000 2.2× 116 3.9k
Andrew M. Hall United Kingdom 31 807 0.7× 335 0.5× 162 0.3× 252 0.5× 177 0.4× 74 2.9k
C. Ronald Scott United States 36 931 0.8× 2.2k 3.6× 409 0.8× 671 1.4× 826 1.8× 81 4.7k
Johannes Häberle Switzerland 36 2.5k 2.2× 657 1.1× 707 1.3× 974 2.0× 2.9k 6.2× 194 4.9k
Bradford L. Therrell United States 31 1.0k 0.9× 236 0.4× 940 1.7× 1.3k 2.7× 1.3k 2.9× 103 3.4k
Alois Lang Austria 27 899 0.8× 196 0.3× 253 0.5× 125 0.3× 155 0.3× 104 3.2k

Countries citing papers authored by Michele Caggana

Since Specialization
Citations

This map shows the geographic impact of Michele Caggana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Caggana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Caggana more than expected).

Fields of papers citing papers by Michele Caggana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Caggana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Caggana. The network helps show where Michele Caggana may publish in the future.

Co-authorship network of co-authors of Michele Caggana

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Caggana. A scholar is included among the top collaborators of Michele Caggana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Caggana. Michele Caggana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kellar‐Guenther, Yvonne, Yu‐Fen Chou, Morna J. Dorsey, et al.. (2024). Defining the Minimal Long-Term Follow-Up Data Elements for Newborn Screening. International Journal of Neonatal Screening. 10(2). 37–37. 1 indexed citations
2.
3.
Park, Sunju, Roxana Moslehi, Wendy K. Chung, et al.. (2023). Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Clinical Biochemistry. 118. 110614–110614. 3 indexed citations
4.
Tavakoli, Norma P., Sunju Park, Michele Caggana, et al.. (2023). Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays. International Journal of Neonatal Screening. 9(1). 13–13. 3 indexed citations
5.
Parisi, Melissa A., Michele Caggana, Jennifer L. Cohen, et al.. (2023). When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(1). 44–55. 8 indexed citations
6.
Hartnett, M. J., Michele A. Lloyd-Puryear, Norma P. Tavakoli, et al.. (2022). Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. International Journal of Neonatal Screening. 8(4). 50–50. 12 indexed citations
7.
Gruber, Dorota, Michele A. Lloyd-Puryear, Mena Scavina, et al.. (2022). Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 190(2). 197–205. 14 indexed citations
8.
9.
Wasserstein, Melissa, Michele Caggana, Michael H. Gelb, et al.. (2020). ScreenPlus: A comprehensive, dynamic, multi-disorder newborn screening pilot program. Molecular Genetics and Metabolism. 129(2). S160–S160. 6 indexed citations
10.
Giannakou, Andreas, Denise M. Kay, Wei Emma Zhang, et al.. (2018). Copy number variants in hypoplastic right heart syndrome. American Journal of Medical Genetics Part A. 176(12). 2760–2767. 7 indexed citations
11.
Yeung, Edwina, Germaine M. Buck Louis, David A. Lawrence, et al.. (2016). Eliciting parental support for the use of newborn blood spots for pediatric research. BMC Medical Research Methodology. 16(1). 14–14. 28 indexed citations
12.
13.
Vogel, Beth, Darius J. Adams, Kristin D׳Aco, et al.. (2015). Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines. Molecular Genetics and Metabolism. 114(4). 599–603. 84 indexed citations
14.
Kay, Denise M., E. Langfelder-Schwind, J. DeCelie-Germana, et al.. (2015). Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening. Pediatric Pulmonology. 50(8). 771–780. 19 indexed citations
15.
Kay, Denise M., Ruzong Fan, Aiyi Liu, et al.. (2014). Novel copy-number variants in a population-based investigation of classic heterotaxy. Genetics in Medicine. 17(5). 348–357. 25 indexed citations
16.
Kirmse, Brian, Charlotte V. Hobbs, Michele Caggana, et al.. (2012). Abnormal Newborn Screens and Acylcarnitines in HIV-exposed and ARV-exposed Infants. The Pediatric Infectious Disease Journal. 32(2). 146–150. 18 indexed citations
17.
Carter, Tonia C., Denise M. Kay, Marilyn L. Browne, et al.. (2012). Hirschsprung’s disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation. Journal of Human Genetics. 57(8). 485–493. 27 indexed citations
18.
Caggana, Michele, et al.. (2008). 15. Newborn screening for Krabbe disease in New York state: Experience from the first year. Molecular Genetics and Metabolism. 93(2). 17–17. 1 indexed citations
19.
Mohamed, Hisham, et al.. (2005). Circulating tumor cells: capture with a micromachined device. TechConnect Briefs. 1(2005). 1–4. 4 indexed citations
20.
Caggana, Michele, Grace A. Ashley, Robert J. Desnick, & Christine M. Eng. (1997). Fabry disease: Molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22.1. American Journal of Medical Genetics. 71(3). 329–335. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Levtchenko Breakdown of academic impact, for papers by Fred Lorey Breakdown of academic impact, for papers by Angelo Minucci Breakdown of academic impact, for papers by Rikke Nielsen Breakdown of academic impact, for papers by David Dimmock Breakdown of academic impact, for papers by Andrew M. Hall Breakdown of academic impact, for papers by C. Ronald Scott Breakdown of academic impact, for papers by Johannes Häberle Breakdown of academic impact, for papers by Bradford L. Therrell Breakdown of academic impact, for papers by Alois Lang
Rankless by CCL
2026